Issues & trends
GIRP and its members advocate for sustainable solutions which prioritise medicines availability, accessibility and affordability by outlining the core function of full-service healthcare distributors (also referred to as pharmaceutical full-line wholesalers), being the vital link for the fair, efficient, timely and safe distribution of all medicinal products, including medical devices and other medical supplies, to patients across Europe.
GIRP has direct contact to the EU institutions from the highest decision making to the working level.
GIRP constantly monitors upcoming legislation to reinforce new rules favourable to our sector and to counteract potential negative impacts.
- Delegated Regulation to the Falsified Medicines Directive
- Good Distribution Practice (GDP) guidelines implementation
- European Medicine Verification Organisation
- Medical Devices and In-Vitro Medical Devices Regulation
- Regulation on Veterinary Medicinal Products
- COVID-19 Pandemic
“Fight the Fakes” is a campaign that aims to raise awareness about the dangers of fake medicines. GIRP joining the campaign is in line with the strong involvement of the association and its members in the fight against fake medicines. We believe that a global movement of organisations and individuals will shine light on the negative impact that fake medicines have on people around the globe and will reduce the negative consequences on individuals worldwide.
#medsdisposal is a campaign to raise awareness on how to dispose of unused or expired medicines appropriately in Europe, bringing information on current disposal schemes in European countries to one place. GIRP, as the umbrella organization of pharmaceutical full-line wholesalers in Europe, decided to support this joint initiative among European healthcare associations, industry and student organisations, including AESGP, CED, EFPIA, EPSA, EurEau, Medicines For Europe and PGEU.
The International Federation of Pharmaceutical Wholesalers’ (IFPW) role is to help its members and stakeholders advance the safe, efficient and continuous access to pharmaceuticals worldwide through the promotion of good distribution practices and services.